NORTHERN TRUST CORP - JASPER THERAPEUTICS INC ownership

JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 24 filers reported holding JASPER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of JASPER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$108,436
-48.9%
154,9090.0%0.00%
Q2 2023$212,225
-24.5%
154,909
-0.2%
0.00%
Q1 2023$281,068
+2612.2%
155,286
+623.6%
0.00%
Q4 2022$10,363
-39.0%
21,4600.0%0.00%
Q3 2022$17,000
-58.5%
21,4600.0%0.00%
Q2 2022$41,000
-43.1%
21,460
+5.8%
0.00%
Q1 2022$72,000
-54.7%
20,2890.0%0.00%
Q4 2021$159,00020,2890.00%
Other shareholders
JASPER THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 5,852,982$20,778,00019.52%
Velan Capital Investment Management LP 3,219,036$10,180,0009.45%
Abingworth LLP 5,628,558$19,531,0005.54%
SECTORAL ASSET MANAGEMENT INC 675,000$2,396,0000.42%
KINGDON CAPITAL MANAGEMENT, L.L.C. 540,000$1,917,0000.20%
Vahanian & Associates Financial Planning Inc. 10,000$36,0000.08%
Forefront Analytics, LLC 32,550$118,0000.04%
Citadel Advisors 2,994,580$10,631,0000.00%
FEDERATED HERMES, INC. 251,697$894,0000.00%
Ionic Capital Management LLC 100$00.00%
View complete list of JASPER THERAPEUTICS INC shareholders